nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—attention deficit hyperactivity disorder—Bupropion—obesity	0.108	1	CpDpCtD
Methamphetamine—Diethylpropion—obesity	0.0628	0.296	CrCtD
Methamphetamine—Phenylpropanolamine—obesity	0.0609	0.287	CrCtD
Methamphetamine—Phentermine—obesity	0.0518	0.244	CrCtD
Methamphetamine—Benzphetamine—obesity	0.0366	0.173	CrCtD
Methamphetamine—Appetite Suppression—Diethylpropion—obesity	0.0359	0.114	CiPCiCtD
Methamphetamine—Increased Sympathetic Activity—Phendimetrazine—obesity	0.0359	0.114	CiPCiCtD
Methamphetamine—Appetite Suppression—Phendimetrazine—obesity	0.0359	0.114	CiPCiCtD
Methamphetamine—Increased Sympathetic Activity—Benzphetamine—obesity	0.0359	0.114	CiPCiCtD
Methamphetamine—Appetite Suppression—Benzphetamine—obesity	0.0359	0.114	CiPCiCtD
Methamphetamine—Increased Sympathetic Activity—Phentermine—obesity	0.0359	0.114	CiPCiCtD
Methamphetamine—Appetite Suppression—Phentermine—obesity	0.0359	0.114	CiPCiCtD
Methamphetamine—Increased Sympathetic Activity—Diethylpropion—obesity	0.0359	0.114	CiPCiCtD
Methamphetamine—SLC6A4—obesity	0.0319	1	CbGaD
Methamphetamine—Appetite Suppression—Sibutramine—obesity	0.0272	0.0865	CiPCiCtD
Methamphetamine—SLC18A2—Benzphetamine—obesity	0.0141	0.0984	CbGbCtD
Methamphetamine—MAOB—Phentermine—obesity	0.00996	0.0697	CbGbCtD
Methamphetamine—SLC6A3—Diethylpropion—obesity	0.00923	0.0646	CbGbCtD
Methamphetamine—MAOA—Phentermine—obesity	0.00783	0.0548	CbGbCtD
Methamphetamine—MAOA—Phenylpropanolamine—obesity	0.00747	0.0523	CbGbCtD
Methamphetamine—SLC6A3—Sibutramine—obesity	0.00699	0.049	CbGbCtD
Methamphetamine—SLC6A3—Phendimetrazine—obesity	0.00699	0.049	CbGbCtD
Methamphetamine—SLC6A2—Diethylpropion—obesity	0.00675	0.0473	CbGbCtD
Methamphetamine—SLC6A4—Sibutramine—obesity	0.00612	0.0428	CbGbCtD
Methamphetamine—SLC6A3—Benzphetamine—obesity	0.0053	0.0371	CbGbCtD
Methamphetamine—SLC6A3—Phentermine—obesity	0.0053	0.0371	CbGbCtD
Methamphetamine—Amfecloral—Phentermine—obesity	0.00525	0.0397	CrCrCtD
Methamphetamine—SLC6A2—Sibutramine—obesity	0.00512	0.0358	CbGbCtD
Methamphetamine—SLC6A2—Phendimetrazine—obesity	0.00512	0.0358	CbGbCtD
Methamphetamine—SLC6A3—Phenylpropanolamine—obesity	0.00506	0.0354	CbGbCtD
Methamphetamine—Phenformin—Phentermine—obesity	0.00492	0.0373	CrCrCtD
Methamphetamine—Ephedrine—Phenylpropanolamine—obesity	0.0049	0.0371	CrCrCtD
Methamphetamine—Pseudoephedrine—Phenylpropanolamine—obesity	0.0049	0.0371	CrCrCtD
Methamphetamine—SLC22A3—Cimetidine—obesity	0.00489	0.0342	CbGbCtD
Methamphetamine—Selegiline—Diethylpropion—obesity	0.00481	0.0364	CrCrCtD
Methamphetamine—Phenylpropanolamine—Phentermine—obesity	0.00464	0.0351	CrCrCtD
Methamphetamine—SLC6A4—Phentermine—obesity	0.00464	0.0325	CbGbCtD
Methamphetamine—SLC6A3—Bupropion—obesity	0.00451	0.0316	CbGbCtD
Methamphetamine—Tolazoline—Phentermine—obesity	0.00439	0.0332	CrCrCtD
Methamphetamine—Phenol—Phenylpropanolamine—obesity	0.00427	0.0323	CrCrCtD
Methamphetamine—Pseudoephedrine—Phentermine—obesity	0.00417	0.0316	CrCrCtD
Methamphetamine—Ephedrine—Phentermine—obesity	0.00417	0.0316	CrCrCtD
Methamphetamine—Lacosamide—Phentermine—obesity	0.00417	0.0316	CrCrCtD
Methamphetamine—Phenelzine—Phenylpropanolamine—obesity	0.0041	0.031	CrCrCtD
Methamphetamine—Selegiline—Phentermine—obesity	0.00397	0.0301	CrCrCtD
Methamphetamine—Phentermine—Phenylpropanolamine—obesity	0.00394	0.0299	CrCrCtD
Methamphetamine—SLC6A2—Benzphetamine—obesity	0.00388	0.0272	CbGbCtD
Methamphetamine—SLC6A2—Phentermine—obesity	0.00388	0.0272	CbGbCtD
Methamphetamine—Pargyline—Phentermine—obesity	0.00379	0.0287	CrCrCtD
Methamphetamine—Fenproporex—Phentermine—obesity	0.00379	0.0287	CrCrCtD
Methamphetamine—Bethanidine—Phentermine—obesity	0.00379	0.0287	CrCrCtD
Methamphetamine—SLC6A2—Phenylpropanolamine—obesity	0.0037	0.0259	CbGbCtD
Methamphetamine—Benzyl alcohol—Phenylpropanolamine—obesity	0.00367	0.0278	CrCrCtD
Methamphetamine—Phenol—Phentermine—obesity	0.00363	0.0275	CrCrCtD
Methamphetamine—Mephentermine—Phentermine—obesity	0.00363	0.0275	CrCrCtD
Methamphetamine—ADRA2A—Benzphetamine—obesity	0.0035	0.0245	CbGbCtD
Methamphetamine—Phenelzine—Phentermine—obesity	0.00349	0.0264	CrCrCtD
Methamphetamine—ADRA2A—Phenylpropanolamine—obesity	0.00334	0.0234	CbGbCtD
Methamphetamine—Dextroamphetamine—Diethylpropion—obesity	0.00332	0.0252	CrCrCtD
Methamphetamine—Amphetamine—Diethylpropion—obesity	0.00332	0.0252	CrCrCtD
Methamphetamine—SLC6A2—Bupropion—obesity	0.0033	0.0231	CbGbCtD
Methamphetamine—Amphetamine—Phenylpropanolamine—obesity	0.00323	0.0244	CrCrCtD
Methamphetamine—Dextroamphetamine—Phenylpropanolamine—obesity	0.00323	0.0244	CrCrCtD
Methamphetamine—Benzyl alcohol—Phentermine—obesity	0.00312	0.0236	CrCrCtD
Methamphetamine—SLC22A5—Cimetidine—obesity	0.00303	0.0212	CbGbCtD
Methamphetamine—Phenacemide—Phentermine—obesity	0.00283	0.0214	CrCrCtD
Methamphetamine—Selegiline—Benzphetamine—obesity	0.00281	0.0213	CrCrCtD
Methamphetamine—Amphetamine—Phentermine—obesity	0.00274	0.0208	CrCrCtD
Methamphetamine—Dextroamphetamine—Phentermine—obesity	0.00274	0.0208	CrCrCtD
Methamphetamine—Psychotic episode—Benzphetamine—obesity	0.00274	0.0945	CcSEcCtD
Methamphetamine—Fenproporex—Benzphetamine—obesity	0.00268	0.0203	CrCrCtD
Methamphetamine—Pargyline—Benzphetamine—obesity	0.00268	0.0203	CrCrCtD
Methamphetamine—L-Phenylalanine—Diethylpropion—obesity	0.00253	0.0191	CrCrCtD
Methamphetamine—Psychotic episode—Phendimetrazine—obesity	0.0025	0.0862	CcSEcCtD
Methamphetamine—L-Phenylalanine—Phenylpropanolamine—obesity	0.00245	0.0186	CrCrCtD
Methamphetamine—L-Phenylalanine—Phentermine—obesity	0.00209	0.0158	CrCrCtD
Methamphetamine—Psychotic episode—Phentermine—obesity	0.00204	0.0704	CcSEcCtD
Methamphetamine—Amphetamine—Benzphetamine—obesity	0.00194	0.0147	CrCrCtD
Methamphetamine—Dextroamphetamine—Benzphetamine—obesity	0.00194	0.0147	CrCrCtD
Methamphetamine—Psychotic episode—Diethylpropion—obesity	0.00178	0.0613	CcSEcCtD
Methamphetamine—Tourette's disorder—Sibutramine—obesity	0.00166	0.0573	CcSEcCtD
Methamphetamine—CYP2D6—Phentermine—obesity	0.00116	0.00814	CbGbCtD
Methamphetamine—CYP2D6—Bupropion—obesity	0.000989	0.00692	CbGbCtD
Methamphetamine—Psychotic episode—Sibutramine—obesity	0.000903	0.0312	CcSEcCtD
Methamphetamine—Dysphoria—Phenylpropanolamine—obesity	0.000856	0.0295	CcSEcCtD
Methamphetamine—Dysphoria—Phentermine—obesity	0.000819	0.0282	CcSEcCtD
Methamphetamine—CYP2D6—Cimetidine—obesity	0.000726	0.00508	CbGbCtD
Methamphetamine—Dysphoria—Diethylpropion—obesity	0.000712	0.0246	CcSEcCtD
Methamphetamine—Digestion impaired—Benzphetamine—obesity	0.000711	0.0245	CcSEcCtD
Methamphetamine—SLC6A2—sympathetic nervous system—obesity	0.000623	0.0883	CbGeAlD
Methamphetamine—Digestion impaired—Phentermine—obesity	0.00053	0.0183	CcSEcCtD
Methamphetamine—TAAR1—respiratory system—obesity	0.000519	0.0737	CbGeAlD
Methamphetamine—Digestion impaired—Diethylpropion—obesity	0.000461	0.0159	CcSEcCtD
Methamphetamine—SLC6A2—autonomic nervous system—obesity	0.000419	0.0594	CbGeAlD
Methamphetamine—Psychotic disorder—Benzphetamine—obesity	0.000337	0.0116	CcSEcCtD
Methamphetamine—SLC18A1—adrenal gland—obesity	0.000335	0.0475	CbGeAlD
Methamphetamine—Euphoric mood—Phenylpropanolamine—obesity	0.000318	0.011	CcSEcCtD
Methamphetamine—Dysphoria—Bupropion—obesity	0.000316	0.0109	CcSEcCtD
Methamphetamine—Psychotic disorder—Phendimetrazine—obesity	0.000307	0.0106	CcSEcCtD
Methamphetamine—Euphoric mood—Phentermine—obesity	0.000304	0.0105	CcSEcCtD
Methamphetamine—SLC18A1—endocrine gland—obesity	0.00029	0.0412	CbGeAlD
Methamphetamine—Euphoric mood—Diethylpropion—obesity	0.000265	0.00913	CcSEcCtD
Methamphetamine—Psychotic disorder—Phenylpropanolamine—obesity	0.000262	0.00905	CcSEcCtD
Methamphetamine—Psychotic disorder—Phentermine—obesity	0.000251	0.00866	CcSEcCtD
Methamphetamine—SLC6A3—hindbrain—obesity	0.000219	0.031	CbGeAlD
Methamphetamine—Psychotic disorder—Diethylpropion—obesity	0.000218	0.00753	CcSEcCtD
Methamphetamine—Psychotic disorder—Cimetidine—obesity	0.000208	0.00717	CcSEcCtD
Methamphetamine—Erectile dysfunction—Phentermine—obesity	0.000205	0.00706	CcSEcCtD
Methamphetamine—Digestion impaired—Bupropion—obesity	0.000204	0.00705	CcSEcCtD
Methamphetamine—SLC6A4—hindbrain—obesity	0.0002	0.0284	CbGeAlD
Methamphetamine—Tremor—Benzphetamine—obesity	0.000195	0.00672	CcSEcCtD
Methamphetamine—Agitation—Benzphetamine—obesity	0.000191	0.00659	CcSEcCtD
Methamphetamine—MAOB—hindbrain—obesity	0.00019	0.027	CbGeAlD
Methamphetamine—Palpitations—Benzphetamine—obesity	0.000184	0.00633	CcSEcCtD
Methamphetamine—Erectile dysfunction—Diethylpropion—obesity	0.000178	0.00614	CcSEcCtD
Methamphetamine—Tremor—Phendimetrazine—obesity	0.000177	0.00612	CcSEcCtD
Methamphetamine—Agitation—Phendimetrazine—obesity	0.000174	0.006	CcSEcCtD
Methamphetamine—Erectile dysfunction—Cimetidine—obesity	0.000169	0.00584	CcSEcCtD
Methamphetamine—Palpitations—Phendimetrazine—obesity	0.000167	0.00577	CcSEcCtD
Methamphetamine—Tachycardia—Benzphetamine—obesity	0.000166	0.00571	CcSEcCtD
Methamphetamine—MAOA—hindbrain—obesity	0.000162	0.023	CbGeAlD
Methamphetamine—Insomnia—Benzphetamine—obesity	0.000153	0.00529	CcSEcCtD
Methamphetamine—Tremor—Phenylpropanolamine—obesity	0.000152	0.00523	CcSEcCtD
Methamphetamine—Tachycardia—Phendimetrazine—obesity	0.000151	0.0052	CcSEcCtD
Methamphetamine—Dyspepsia—Benzphetamine—obesity	0.000149	0.00515	CcSEcCtD
Methamphetamine—Agitation—Phenylpropanolamine—obesity	0.000149	0.00513	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Benzphetamine—obesity	0.000146	0.00505	CcSEcCtD
Methamphetamine—Tremor—Phentermine—obesity	0.000145	0.005	CcSEcCtD
Methamphetamine—Agitation—Phentermine—obesity	0.000142	0.00491	CcSEcCtD
Methamphetamine—Insomnia—Phendimetrazine—obesity	0.00014	0.00482	CcSEcCtD
Methamphetamine—Palpitations—Phentermine—obesity	0.000137	0.00472	CcSEcCtD
Methamphetamine—Urticaria—Benzphetamine—obesity	0.000135	0.00465	CcSEcCtD
Methamphetamine—Euphoric mood—Sibutramine—obesity	0.000135	0.00464	CcSEcCtD
Methamphetamine—SLC6A3—respiratory system—obesity	0.000133	0.0189	CbGeAlD
Methamphetamine—Constipation—Phendimetrazine—obesity	0.000132	0.00456	CcSEcCtD
Methamphetamine—Tachycardia—Phenylpropanolamine—obesity	0.000129	0.00445	CcSEcCtD
Methamphetamine—Tremor—Diethylpropion—obesity	0.000126	0.00435	CcSEcCtD
Methamphetamine—Hypersensitivity—Benzphetamine—obesity	0.000125	0.00431	CcSEcCtD
Methamphetamine—Agitation—Diethylpropion—obesity	0.000124	0.00427	CcSEcCtD
Methamphetamine—Tachycardia—Phentermine—obesity	0.000123	0.00425	CcSEcCtD
Methamphetamine—SLC6A4—respiratory system—obesity	0.000122	0.0174	CbGeAlD
Methamphetamine—Insomnia—Phenylpropanolamine—obesity	0.000119	0.00412	CcSEcCtD
Methamphetamine—SLC18A2—adipose tissue—obesity	0.000119	0.0169	CbGeAlD
Methamphetamine—Palpitations—Diethylpropion—obesity	0.000119	0.00411	CcSEcCtD
Methamphetamine—Agitation—Cimetidine—obesity	0.000118	0.00406	CcSEcCtD
Methamphetamine—Euphoric mood—Bupropion—obesity	0.000117	0.00405	CcSEcCtD
Methamphetamine—MAOB—respiratory system—obesity	0.000116	0.0165	CbGeAlD
Methamphetamine—Diarrhoea—Benzphetamine—obesity	0.000116	0.004	CcSEcCtD
Methamphetamine—Phenelzine—GPT—obesity	0.000116	0.14	CrCbGaD
Methamphetamine—Insomnia—Phentermine—obesity	0.000114	0.00394	CcSEcCtD
Methamphetamine—Constipation—Phenylpropanolamine—obesity	0.000113	0.00389	CcSEcCtD
Methamphetamine—SLC18A2—digestive system—obesity	0.000112	0.0159	CbGeAlD
Methamphetamine—Dizziness—Benzphetamine—obesity	0.000112	0.00387	CcSEcCtD
Methamphetamine—Dyspepsia—Phentermine—obesity	0.000111	0.00384	CcSEcCtD
Methamphetamine—Psychotic disorder—Sibutramine—obesity	0.000111	0.00383	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Phentermine—obesity	0.000109	0.00376	CcSEcCtD
Methamphetamine—Constipation—Phentermine—obesity	0.000108	0.00373	CcSEcCtD
Methamphetamine—SLC6A2—respiratory system—obesity	0.000108	0.0153	CbGeAlD
Methamphetamine—Tachycardia—Diethylpropion—obesity	0.000107	0.0037	CcSEcCtD
Methamphetamine—SLC18A2—adrenal gland—obesity	0.000107	0.0152	CbGeAlD
Methamphetamine—Headache—Benzphetamine—obesity	0.000106	0.00366	CcSEcCtD
Methamphetamine—Diarrhoea—Phendimetrazine—obesity	0.000106	0.00365	CcSEcCtD
Methamphetamine—MAOA—islet of Langerhans—obesity	0.000105	0.0149	CbGeAlD
Methamphetamine—Dizziness—Phendimetrazine—obesity	0.000102	0.00353	CcSEcCtD
Methamphetamine—Tachycardia—Cimetidine—obesity	0.000102	0.00352	CcSEcCtD
Methamphetamine—Urticaria—Phentermine—obesity	0.0001	0.00346	CcSEcCtD
Methamphetamine—Insomnia—Diethylpropion—obesity	9.94e-05	0.00343	CcSEcCtD
Methamphetamine—MAOA—respiratory system—obesity	9.92e-05	0.0141	CbGeAlD
Methamphetamine—MAOB—adrenal cortex—obesity	9.76e-05	0.0138	CbGeAlD
Methamphetamine—Hypersensitivity—Phenylpropanolamine—obesity	9.73e-05	0.00336	CcSEcCtD
Methamphetamine—Headache—Phendimetrazine—obesity	9.68e-05	0.00334	CcSEcCtD
Methamphetamine—Psychotic disorder—Bupropion—obesity	9.68e-05	0.00334	CcSEcCtD
Methamphetamine—Dyspepsia—Diethylpropion—obesity	9.68e-05	0.00334	CcSEcCtD
Methamphetamine—Lacosamide—CA3—obesity	9.66e-05	0.117	CrCbGaD
Methamphetamine—CYP2D6—hindbrain—obesity	9.65e-05	0.0137	CbGeAlD
Methamphetamine—Gastrointestinal disorder—Diethylpropion—obesity	9.49e-05	0.00327	CcSEcCtD
Methamphetamine—Constipation—Diethylpropion—obesity	9.4e-05	0.00324	CcSEcCtD
Methamphetamine—Amphetamine—CARTPT—obesity	9.28e-05	0.113	CrCbGaD
Methamphetamine—SLC18A2—endocrine gland—obesity	9.27e-05	0.0132	CbGeAlD
Methamphetamine—SLC22A5—respiratory system—obesity	9.14e-05	0.013	CbGeAlD
Methamphetamine—Erectile dysfunction—Sibutramine—obesity	9.05e-05	0.00312	CcSEcCtD
Methamphetamine—Constipation—Cimetidine—obesity	8.94e-05	0.00309	CcSEcCtD
Methamphetamine—MAOB—cardiovascular system—obesity	8.91e-05	0.0126	CbGeAlD
Methamphetamine—Urticaria—Diethylpropion—obesity	8.73e-05	0.00301	CcSEcCtD
Methamphetamine—Dizziness—Phenylpropanolamine—obesity	8.73e-05	0.00301	CcSEcCtD
Methamphetamine—Diarrhoea—Phentermine—obesity	8.64e-05	0.00298	CcSEcCtD
Methamphetamine—SLC22A3—adipose tissue—obesity	8.49e-05	0.012	CbGeAlD
Methamphetamine—SLC18A2—liver—obesity	8.36e-05	0.0119	CbGeAlD
Methamphetamine—Dizziness—Phentermine—obesity	8.36e-05	0.00288	CcSEcCtD
Methamphetamine—MAOA—adrenal cortex—obesity	8.33e-05	0.0118	CbGeAlD
Methamphetamine—ADRA2A—islet of Langerhans—obesity	8.06e-05	0.0114	CbGeAlD
Methamphetamine—ADRA2C—adrenal cortex—obesity	8.01e-05	0.0114	CbGeAlD
Methamphetamine—Headache—Phentermine—obesity	7.92e-05	0.00273	CcSEcCtD
Methamphetamine—Erectile dysfunction—Bupropion—obesity	7.89e-05	0.00272	CcSEcCtD
Methamphetamine—MAOB—pituitary gland—obesity	7.89e-05	0.0112	CbGeAlD
Methamphetamine—MAOB—adipose tissue—obesity	7.85e-05	0.0111	CbGeAlD
Methamphetamine—SLC6A4—digestive system—obesity	7.78e-05	0.011	CbGeAlD
Methamphetamine—Hypersensitivity—Cimetidine—obesity	7.71e-05	0.00266	CcSEcCtD
Methamphetamine—SLC22A5—adrenal cortex—obesity	7.67e-05	0.0109	CbGeAlD
Methamphetamine—SLC22A3—adrenal gland—obesity	7.61e-05	0.0108	CbGeAlD
Methamphetamine—Aspartame—TRPV1—obesity	7.6e-05	0.0922	CrCbGaD
Methamphetamine—MAOA—cardiovascular system—obesity	7.6e-05	0.0108	CbGeAlD
Methamphetamine—Diarrhoea—Diethylpropion—obesity	7.52e-05	0.00259	CcSEcCtD
Methamphetamine—Euphoric mood—Topiramate—obesity	7.47e-05	0.00258	CcSEcCtD
Methamphetamine—Phenelzine—AOC3—obesity	7.46e-05	0.0904	CrCbGaD
Methamphetamine—MAOB—digestive system—obesity	7.39e-05	0.0105	CbGeAlD
Methamphetamine—Dizziness—Diethylpropion—obesity	7.27e-05	0.00251	CcSEcCtD
Methamphetamine—Diarrhoea—Cimetidine—obesity	7.16e-05	0.00247	CcSEcCtD
Methamphetamine—MAOB—adrenal gland—obesity	7.04e-05	0.00999	CbGeAlD
Methamphetamine—Dizziness—Cimetidine—obesity	6.92e-05	0.00239	CcSEcCtD
Methamphetamine—Headache—Diethylpropion—obesity	6.89e-05	0.00238	CcSEcCtD
Methamphetamine—MAOA—pituitary gland—obesity	6.73e-05	0.00954	CbGeAlD
Methamphetamine—MAOA—adipose tissue—obesity	6.7e-05	0.00951	CbGeAlD
Methamphetamine—SLC22A3—endocrine gland—obesity	6.6e-05	0.00937	CbGeAlD
Methamphetamine—Headache—Cimetidine—obesity	6.55e-05	0.00226	CcSEcCtD
Methamphetamine—SLC6A2—adrenal gland—obesity	6.52e-05	0.00925	CbGeAlD
Methamphetamine—ADRA2C—pituitary gland—obesity	6.47e-05	0.00918	CbGeAlD
Methamphetamine—ADRA2C—adipose tissue—obesity	6.44e-05	0.00914	CbGeAlD
Methamphetamine—SLC6A4—endocrine gland—obesity	6.43e-05	0.00912	CbGeAlD
Methamphetamine—Tremor—Sibutramine—obesity	6.41e-05	0.00221	CcSEcCtD
Methamphetamine—MAOA—digestive system—obesity	6.31e-05	0.00895	CbGeAlD
Methamphetamine—Agitation—Sibutramine—obesity	6.29e-05	0.00217	CcSEcCtD
Methamphetamine—Palpitations—Orlistat—obesity	6.25e-05	0.00216	CcSEcCtD
Methamphetamine—SLC22A5—pituitary gland—obesity	6.2e-05	0.00879	CbGeAlD
Methamphetamine—SLC22A5—adipose tissue—obesity	6.17e-05	0.00875	CbGeAlD
Methamphetamine—Psychotic disorder—Topiramate—obesity	6.17e-05	0.00213	CcSEcCtD
Methamphetamine—MAOB—endocrine gland—obesity	6.11e-05	0.00867	CbGeAlD
Methamphetamine—Palpitations—Sibutramine—obesity	6.05e-05	0.00209	CcSEcCtD
Methamphetamine—MAOA—adrenal gland—obesity	6.01e-05	0.00853	CbGeAlD
Methamphetamine—SLC22A3—liver—obesity	5.95e-05	0.00844	CbGeAlD
Methamphetamine—SLC22A5—digestive system—obesity	5.81e-05	0.00824	CbGeAlD
Methamphetamine—ADRA2C—adrenal gland—obesity	5.78e-05	0.0082	CbGeAlD
Methamphetamine—SLC6A2—endocrine gland—obesity	5.66e-05	0.00803	CbGeAlD
Methamphetamine—Tremor—Bupropion—obesity	5.59e-05	0.00193	CcSEcCtD
Methamphetamine—SLC22A5—adrenal gland—obesity	5.54e-05	0.00785	CbGeAlD
Methamphetamine—MAOB—liver—obesity	5.51e-05	0.00781	CbGeAlD
Methamphetamine—Agitation—Bupropion—obesity	5.49e-05	0.00189	CcSEcCtD
Methamphetamine—Tachycardia—Sibutramine—obesity	5.45e-05	0.00188	CcSEcCtD
Methamphetamine—Palpitations—Bupropion—obesity	5.27e-05	0.00182	CcSEcCtD
Methamphetamine—Insomnia—Orlistat—obesity	5.22e-05	0.0018	CcSEcCtD
Methamphetamine—MAOA—endocrine gland—obesity	5.21e-05	0.00739	CbGeAlD
Methamphetamine—ADRA2A—pituitary gland—obesity	5.16e-05	0.00732	CbGeAlD
Methamphetamine—ADRA2A—adipose tissue—obesity	5.14e-05	0.00729	CbGeAlD
Methamphetamine—Dyspepsia—Orlistat—obesity	5.08e-05	0.00175	CcSEcCtD
Methamphetamine—Insomnia—Sibutramine—obesity	5.05e-05	0.00174	CcSEcCtD
Methamphetamine—Erectile dysfunction—Topiramate—obesity	5.03e-05	0.00173	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Orlistat—obesity	4.98e-05	0.00172	CcSEcCtD
Methamphetamine—Dyspepsia—Sibutramine—obesity	4.92e-05	0.0017	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Sibutramine—obesity	4.82e-05	0.00166	CcSEcCtD
Methamphetamine—Constipation—Sibutramine—obesity	4.78e-05	0.00165	CcSEcCtD
Methamphetamine—Tachycardia—Bupropion—obesity	4.75e-05	0.00164	CcSEcCtD
Methamphetamine—MAOA—liver—obesity	4.7e-05	0.00667	CbGeAlD
Methamphetamine—ADRA2A—adrenal gland—obesity	4.61e-05	0.00654	CbGeAlD
Methamphetamine—Urticaria—Orlistat—obesity	4.59e-05	0.00158	CcSEcCtD
Methamphetamine—ADRA2C—liver—obesity	4.52e-05	0.00641	CbGeAlD
Methamphetamine—Urticaria—Sibutramine—obesity	4.44e-05	0.00153	CcSEcCtD
Methamphetamine—Insomnia—Bupropion—obesity	4.41e-05	0.00152	CcSEcCtD
Methamphetamine—SLC22A5—liver—obesity	4.33e-05	0.00614	CbGeAlD
Methamphetamine—Dyspepsia—Bupropion—obesity	4.29e-05	0.00148	CcSEcCtD
Methamphetamine—Hypersensitivity—Orlistat—obesity	4.25e-05	0.00147	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Bupropion—obesity	4.21e-05	0.00145	CcSEcCtD
Methamphetamine—Constipation—Bupropion—obesity	4.17e-05	0.00144	CcSEcCtD
Methamphetamine—Hypersensitivity—Sibutramine—obesity	4.12e-05	0.00142	CcSEcCtD
Methamphetamine—ADRA2A—endocrine gland—obesity	4e-05	0.00567	CbGeAlD
Methamphetamine—Diarrhoea—Orlistat—obesity	3.95e-05	0.00136	CcSEcCtD
Methamphetamine—Urticaria—Bupropion—obesity	3.87e-05	0.00134	CcSEcCtD
Methamphetamine—Diarrhoea—Sibutramine—obesity	3.82e-05	0.00132	CcSEcCtD
Methamphetamine—Dizziness—Orlistat—obesity	3.82e-05	0.00132	CcSEcCtD
Methamphetamine—CYP2D6—digestive system—obesity	3.75e-05	0.00532	CbGeAlD
Methamphetamine—Dizziness—Sibutramine—obesity	3.7e-05	0.00127	CcSEcCtD
Methamphetamine—Headache—Orlistat—obesity	3.62e-05	0.00125	CcSEcCtD
Methamphetamine—Hypersensitivity—Bupropion—obesity	3.59e-05	0.00124	CcSEcCtD
Methamphetamine—Tremor—Topiramate—obesity	3.56e-05	0.00123	CcSEcCtD
Methamphetamine—Headache—Sibutramine—obesity	3.5e-05	0.00121	CcSEcCtD
Methamphetamine—Agitation—Topiramate—obesity	3.49e-05	0.00121	CcSEcCtD
Methamphetamine—Phenformin—SLC22A1—obesity	3.39e-05	0.0411	CrCbGaD
Methamphetamine—Dexfenfluramine—HTR2C—obesity	3.36e-05	0.0408	CrCbGaD
Methamphetamine—Palpitations—Topiramate—obesity	3.36e-05	0.00116	CcSEcCtD
Methamphetamine—Diarrhoea—Bupropion—obesity	3.33e-05	0.00115	CcSEcCtD
Methamphetamine—Dizziness—Bupropion—obesity	3.22e-05	0.00111	CcSEcCtD
Methamphetamine—CYP2D6—endocrine gland—obesity	3.1e-05	0.00439	CbGeAlD
Methamphetamine—Headache—Bupropion—obesity	3.05e-05	0.00105	CcSEcCtD
Methamphetamine—Tachycardia—Topiramate—obesity	3.03e-05	0.00104	CcSEcCtD
Methamphetamine—Insomnia—Topiramate—obesity	2.81e-05	0.000968	CcSEcCtD
Methamphetamine—CYP2D6—liver—obesity	2.79e-05	0.00396	CbGeAlD
Methamphetamine—Dexfenfluramine—SLC6A4—obesity	2.79e-05	0.0338	CrCbGaD
Methamphetamine—Dyspepsia—Topiramate—obesity	2.73e-05	0.000942	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Topiramate—obesity	2.68e-05	0.000924	CcSEcCtD
Methamphetamine—Dexfenfluramine—CYP2E1—obesity	2.67e-05	0.0324	CrCbGaD
Methamphetamine—Constipation—Topiramate—obesity	2.65e-05	0.000916	CcSEcCtD
Methamphetamine—Urticaria—Topiramate—obesity	2.47e-05	0.000851	CcSEcCtD
Methamphetamine—Hypersensitivity—Topiramate—obesity	2.29e-05	0.000789	CcSEcCtD
Methamphetamine—Ephedrine—BCHE—obesity	2.15e-05	0.0261	CrCbGaD
Methamphetamine—Phenylpropanolamine—DRD1—obesity	2.12e-05	0.0257	CrCbGaD
Methamphetamine—Diarrhoea—Topiramate—obesity	2.12e-05	0.000733	CcSEcCtD
Methamphetamine—Dizziness—Topiramate—obesity	2.05e-05	0.000708	CcSEcCtD
Methamphetamine—Phenylpropanolamine—ADRB1—obesity	1.97e-05	0.0239	CrCbGaD
Methamphetamine—Headache—Topiramate—obesity	1.94e-05	0.000671	CcSEcCtD
Methamphetamine—Ephedrine—ADRB2—obesity	1.85e-05	0.0224	CrCbGaD
Methamphetamine—Pseudoephedrine—ADRB1—obesity	1.67e-05	0.0202	CrCbGaD
Methamphetamine—Phenylpropanolamine—ADRB2—obesity	1.66e-05	0.0201	CrCbGaD
Methamphetamine—Pseudoephedrine—TNF—obesity	1.58e-05	0.0192	CrCbGaD
Methamphetamine—Nateglinide—PPARG—obesity	1.55e-05	0.0188	CrCbGaD
Methamphetamine—Pseudoephedrine—ADRB2—obesity	1.4e-05	0.017	CrCbGaD
Methamphetamine—Phentermine—SLC6A4—obesity	1.34e-05	0.0163	CrCbGaD
Methamphetamine—Pseudoephedrine—SLC6A4—obesity	1.27e-05	0.0154	CrCbGaD
Methamphetamine—Benzyl alcohol—CYP2E1—obesity	1.24e-05	0.015	CrCbGaD
Methamphetamine—Selegiline—CYP2E1—obesity	1.19e-05	0.0144	CrCbGaD
Methamphetamine—Phenelzine—CYP2E1—obesity	1.05e-05	0.0127	CrCbGaD
Methamphetamine—Amphetamine—SLC6A4—obesity	1.03e-05	0.0125	CrCbGaD
Methamphetamine—Amphetamine—DRD2—obesity	1.03e-05	0.0124	CrCbGaD
Methamphetamine—Nateglinide—ALB—obesity	5.84e-06	0.00708	CrCbGaD
Methamphetamine—CYP2D6—Metabolism—CETP—obesity	5.64e-07	2.59e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—LPL—obesity	5.64e-07	2.59e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—TGFB1—obesity	5.61e-07	2.58e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CAV1—obesity	5.6e-07	2.57e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—FOXO1—obesity	5.6e-07	2.57e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—RPS6KB1—obesity	5.59e-07	2.57e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—APOA1—obesity	5.59e-07	2.57e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—POMC—obesity	5.58e-07	2.56e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—SDC1—obesity	5.58e-07	2.56e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PRL—obesity	5.57e-07	2.56e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PRKCD—obesity	5.56e-07	2.55e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PIK3CB—obesity	5.53e-07	2.54e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—AKR1C3—obesity	5.49e-07	2.52e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—STK11—obesity	5.49e-07	2.52e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—LPL—obesity	5.48e-07	2.51e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CCL2—obesity	5.46e-07	2.51e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PIK3CD—obesity	5.45e-07	2.5e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HTR2A—obesity	5.44e-07	2.5e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—C3—obesity	5.44e-07	2.5e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PLG—obesity	5.43e-07	2.49e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—RHOA—obesity	5.42e-07	2.49e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—SCARB1—obesity	5.4e-07	2.48e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ALB—obesity	5.38e-07	2.47e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—AKT2—obesity	5.37e-07	2.46e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—PIK3R1—obesity	5.36e-07	2.46e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GPX1—obesity	5.34e-07	2.45e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—FOXO3—obesity	5.3e-07	2.43e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ADRB2—obesity	5.28e-07	2.43e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—SREBF1—obesity	5.25e-07	2.41e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CD36—obesity	5.2e-07	2.39e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SOCS1—obesity	5.2e-07	2.39e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PRKCD—obesity	5.2e-07	2.39e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IRS2—obesity	5.17e-07	2.37e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—AGT—obesity	5.16e-07	2.37e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PIK3CD—obesity	5.16e-07	2.37e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PIK3R1—obesity	5.15e-07	2.36e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—NOS3—obesity	5.15e-07	2.36e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—AKT1—obesity	5.14e-07	2.36e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SOCS3—obesity	5.14e-07	2.36e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GOT2—obesity	5.1e-07	2.34e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PIK3CG—obesity	5.1e-07	2.34e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HTR2A—obesity	5.08e-07	2.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—C3—obesity	5.08e-07	2.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—APOE—obesity	5.06e-07	2.32e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—LEP—obesity	5.06e-07	2.32e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—GNB3—obesity	5.03e-07	2.31e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CAV1—obesity	5.01e-07	2.3e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—APOA1—obesity	5e-07	2.3e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—FASN—obesity	4.99e-07	2.29e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—BCHE—obesity	4.97e-07	2.28e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—TYK2—obesity	4.96e-07	2.28e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—PIK3CB—obesity	4.95e-07	2.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IGF2—obesity	4.94e-07	2.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—MTHFR—obesity	4.93e-07	2.26e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PPARG—obesity	4.92e-07	2.26e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—RHOA—obesity	4.92e-07	2.26e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—GNAS—obesity	4.9e-07	2.25e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PIK3R1—obesity	4.87e-07	2.24e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—POMC—obesity	4.86e-07	2.23e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PPARA—obesity	4.84e-07	2.22e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ESR1—obesity	4.83e-07	2.22e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IRS2—obesity	4.83e-07	2.22e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—INS—obesity	4.83e-07	2.22e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—AGT—obesity	4.82e-07	2.21e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—AKT1—obesity	4.8e-07	2.2e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CYP2E1—obesity	4.8e-07	2.2e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—APOB—obesity	4.8e-07	2.2e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—PIK3CA—obesity	4.77e-07	2.19e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—F2—obesity	4.77e-07	2.19e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PRKCB—obesity	4.77e-07	2.19e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PIK3CB—obesity	4.75e-07	2.18e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—NQO1—obesity	4.74e-07	2.18e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—LEP—obesity	4.73e-07	2.17e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—APOE—obesity	4.73e-07	2.17e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—BAD—obesity	4.72e-07	2.16e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PTGS2—obesity	4.71e-07	2.16e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—AGT—obesity	4.69e-07	2.15e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCL5—obesity	4.68e-07	2.15e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CAV1—obesity	4.68e-07	2.15e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—APOA1—obesity	4.67e-07	2.15e-05	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PIK3CA—obesity	4.62e-07	2.12e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—APOE—obesity	4.59e-07	2.11e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—LPL—obesity	4.58e-07	2.1e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PIK3CG—obesity	4.57e-07	2.1e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CAV1—obesity	4.55e-07	2.09e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—SLC2A4—obesity	4.55e-07	2.09e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GCG—obesity	4.55e-07	2.09e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—FOXO1—obesity	4.55e-07	2.09e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—RPS6KB1—obesity	4.54e-07	2.08e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—APOA1—obesity	4.54e-07	2.08e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IRS1—obesity	4.51e-07	2.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ESR1—obesity	4.51e-07	2.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PIK3CB—obesity	4.49e-07	2.06e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CYCS—obesity	4.49e-07	2.06e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PIK3CD—obesity	4.48e-07	2.06e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PRKCB—obesity	4.46e-07	2.05e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—F2—obesity	4.46e-07	2.05e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ALB—obesity	4.43e-07	2.03e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GGT1—obesity	4.41e-07	2.02e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GOT1—obesity	4.41e-07	2.02e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—BAD—obesity	4.4e-07	2.02e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—POMC—obesity	4.35e-07	2e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—NCOA1—obesity	4.34e-07	1.99e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—INS—obesity	4.32e-07	1.98e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—STK11—obesity	4.28e-07	1.96e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CYP19A1—obesity	4.28e-07	1.96e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PIK3CG—obesity	4.27e-07	1.96e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCL2—obesity	4.25e-07	1.95e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PIK3R1—obesity	4.24e-07	1.94e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—NOS3—obesity	4.24e-07	1.94e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PRKCD—obesity	4.22e-07	1.94e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IRS1—obesity	4.22e-07	1.94e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IGF1—obesity	4.18e-07	1.92e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—AKT2—obesity	4.18e-07	1.92e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PIK3CG—obesity	4.14e-07	1.9e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HTR2A—obesity	4.13e-07	1.9e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—C3—obesity	4.12e-07	1.89e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—POMC—obesity	4.06e-07	1.86e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—INS—obesity	4.04e-07	1.85e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PIK3CD—obesity	4.01e-07	1.84e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PPARG—obesity	4e-07	1.84e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—PIK3CA—obesity	3.98e-07	1.83e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—COMT—obesity	3.98e-07	1.83e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCL2—obesity	3.97e-07	1.82e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SERPINE1—obesity	3.97e-07	1.82e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—POMC—obesity	3.94e-07	1.81e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IRS2—obesity	3.92e-07	1.8e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—INS—obesity	3.92e-07	1.8e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PPARGC1A—obesity	3.92e-07	1.8e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GNB3—obesity	3.92e-07	1.8e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AGT—obesity	3.92e-07	1.8e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PIK3CB—obesity	3.91e-07	1.79e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PIK3CA—obesity	3.91e-07	1.79e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IGF1—obesity	3.91e-07	1.79e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—AKT2—obesity	3.9e-07	1.79e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—HMOX1—obesity	3.9e-07	1.79e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—AKT1—obesity	3.9e-07	1.79e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PTGS2—obesity	3.87e-07	1.78e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TYK2—obesity	3.86e-07	1.77e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—LEP—obesity	3.84e-07	1.76e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—APOE—obesity	3.84e-07	1.76e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—RHOA—obesity	3.83e-07	1.76e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GNAS—obesity	3.82e-07	1.75e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CAV1—obesity	3.8e-07	1.75e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—APOA1—obesity	3.8e-07	1.74e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PIK3R1—obesity	3.79e-07	1.74e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NOS3—obesity	3.79e-07	1.74e-05	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—AKT1—obesity	3.77e-07	1.73e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PIK3CD—obesity	3.75e-07	1.72e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—APOB—obesity	3.74e-07	1.72e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—PIK3CA—obesity	3.71e-07	1.71e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SERPINE1—obesity	3.71e-07	1.7e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ESR1—obesity	3.67e-07	1.68e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PIK3CD—obesity	3.64e-07	1.67e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—F2—obesity	3.62e-07	1.66e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PRKCB—obesity	3.62e-07	1.66e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—PIK3CA—obesity	3.61e-07	1.66e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TYK2—obesity	3.61e-07	1.66e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ALB—obesity	3.6e-07	1.65e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—RHOA—obesity	3.58e-07	1.64e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—BAD—obesity	3.58e-07	1.64e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—LPL—obesity	3.57e-07	1.64e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PIK3R1—obesity	3.54e-07	1.63e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NOS3—obesity	3.54e-07	1.63e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PIK3CB—obesity	3.5e-07	1.61e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MTOR—obesity	3.5e-07	1.61e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GPX1—obesity	3.48e-07	1.6e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PIK3CG—obesity	3.46e-07	1.59e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PIK3R1—obesity	3.44e-07	1.58e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—NOS3—obesity	3.44e-07	1.58e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IRS1—obesity	3.43e-07	1.57e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CD36—obesity	3.39e-07	1.56e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PIK3CA—obesity	3.37e-07	1.55e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—POMC—obesity	3.3e-07	1.51e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—INS—obesity	3.28e-07	1.51e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MTOR—obesity	3.27e-07	1.5e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PIK3CB—obesity	3.27e-07	1.5e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—AKT1—obesity	3.25e-07	1.49e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCL2—obesity	3.23e-07	1.48e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—MTHFR—obesity	3.21e-07	1.48e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL6—obesity	3.2e-07	1.47e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—AKT1—obesity	3.19e-07	1.47e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PIK3CB—obesity	3.18e-07	1.46e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IGF1—obesity	3.17e-07	1.46e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AKT2—obesity	3.17e-07	1.46e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PPARA—obesity	3.15e-07	1.45e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PTGS2—obesity	3.15e-07	1.44e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—AGT—obesity	3.05e-07	1.4e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PIK3CD—obesity	3.05e-07	1.4e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MMP9—obesity	3.04e-07	1.4e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—AKT1—obesity	3.03e-07	1.39e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	3.02e-07	1.39e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SERPINE1—obesity	3.01e-07	1.38e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—APOE—obesity	2.99e-07	1.37e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL6—obesity	2.99e-07	1.37e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CAV1—obesity	2.96e-07	1.36e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MAPK8—obesity	2.96e-07	1.36e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—APOA1—obesity	2.96e-07	1.36e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—AKT1—obesity	2.95e-07	1.35e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TYK2—obesity	2.93e-07	1.35e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—RHOA—obesity	2.91e-07	1.33e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PIK3CA—obesity	2.9e-07	1.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PIK3R1—obesity	2.88e-07	1.32e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NOS3—obesity	2.88e-07	1.32e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MMP9—obesity	2.84e-07	1.3e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MAPK8—obesity	2.76e-07	1.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—AKT1—obesity	2.76e-07	1.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PIK3CA—obesity	2.74e-07	1.26e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—STAT3—obesity	2.7e-07	1.24e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PIK3CG—obesity	2.7e-07	1.24e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MTOR—obesity	2.66e-07	1.22e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PIK3CB—obesity	2.66e-07	1.22e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PPARG—obesity	2.61e-07	1.2e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—POMC—obesity	2.57e-07	1.18e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—INS—obesity	2.56e-07	1.17e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—STAT3—obesity	2.53e-07	1.16e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MYC—obesity	2.51e-07	1.15e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TGFB1—obesity	2.51e-07	1.15e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—AKT1—obesity	2.46e-07	1.13e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL6—obesity	2.43e-07	1.11e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PIK3CA—obesity	2.38e-07	1.09e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PIK3CD—obesity	2.37e-07	1.09e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—AKT1—obesity	2.37e-07	1.09e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MYC—obesity	2.35e-07	1.08e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALB—obesity	2.34e-07	1.08e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TGFB1—obesity	2.34e-07	1.08e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MMP9—obesity	2.31e-07	1.06e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MAPK8—obesity	2.24e-07	1.03e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PIK3R1—obesity	2.24e-07	1.03e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—NOS3—obesity	2.24e-07	1.03e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—AKT1—obesity	2.24e-07	1.03e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PIK3CA—obesity	2.13e-07	9.79e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PIK3CB—obesity	2.07e-07	9.5e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—STAT3—obesity	2.05e-07	9.42e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PTGS2—obesity	2.05e-07	9.41e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PIK3CA—obesity	1.99e-07	9.15e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—AKT1—obesity	1.95e-07	8.94e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PIK3CA—obesity	1.94e-07	8.89e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MYC—obesity	1.91e-07	8.75e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TGFB1—obesity	1.9e-07	8.73e-06	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL6—obesity	1.89e-07	8.67e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL6—obesity	1.76e-07	8.1e-06	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—AKT1—obesity	1.74e-07	8e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—AKT1—obesity	1.63e-07	7.47e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PIK3CA—obesity	1.62e-07	7.43e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—AKT1—obesity	1.58e-07	7.26e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL6—obesity	1.43e-07	6.58e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AKT1—obesity	1.32e-07	6.07e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PIK3CA—obesity	1.26e-07	5.79e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—AKT1—obesity	1.03e-07	4.73e-06	CbGpPWpGaD
